N-[[6-(1,1-difluoroethyl)-3-pyridinyl]methyl]-1-[3-fluoro-4-(triazol-1-yl)butyl]triazole-4-carboxamide
C17H19F3N8O — CID 154982629
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[6-(1,1-difluoroethyl)-3-pyridinyl]methyl]-1-[3-fluoro-4-(triazol-1-yl)butyl]triazole-4-carboxamide
N-[[6-(1,1-difluoroethyl)-3-pyridinyl]methyl]-1-[3-fluoro-4-(triazol-1-yl)butyl]triazole-4-carboxamide (PubChem CID 154982629) has the molecular formula C17H19F3N8O and a molecular weight of 408.39 g/mol. Its IUPAC name is N-[[6-(1,1-difluoroethyl)-3-pyridinyl]methyl]-1-[3-fluoro-4-(triazol-1-yl)butyl]triazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[[6-(1,1-difluoroethyl)-3-pyridinyl]methyl]-1-[3-fluoro-4-(triazol-1-yl)butyl]triazole-4-carboxamide |
|---|---|
| PubChem CID | 154982629 |
| Molecular Formula | C17H19F3N8O |
| Molecular Weight | 408.39 g/mol |
| Exact Mass | 408.16 |
| IUPAC Name | N-[[6-(1,1-difluoroethyl)-3-pyridinyl]methyl]-1-[3-fluoro-4-(triazol-1-yl)butyl]triazole-4-carboxamide |
| SMILES | CC(F)(F)c1ccc(CNC(=O)c2cn(CCC(F)Cn3ccnn3)nn2)cn1 |
| InChI | InChI=1S/C17H19F3N8O/c1-17(19,20)15-3-2-12(8-21-15)9-22-16(29)14-11-27(26-24-14)6-4-13(18)10-28-7-5-23-25-28/h2-3,5,7-8,11,13H,4,6,9-10H2,1H3,(H,22,29) |
| InChIKey | OFYSCUOMPFDFHN-UHFFFAOYSA-N |
| XLogP | 1.73 |
| TPSA | 103.41 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 408.39 |
| LogP ≤ 5 | 1.73 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154982629 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.